Search Results for: hepatitis C virus

September 13, 2016September 13, 2016

Battle Against Hepatitis B Gains New Ally: Grass Pollen Allergy Vaccine

Hepatitis B, News

Researchers in Austria developed a new grass pollen allergy vaccine (BM32) that was found to have a potential hepatitis B infection-neutralizing activity. The study, “Immunotherapy With the PreS-based Grass Pollen ... Read more

September 6, 2016

Restaurant Group Highlights Foodborne Illness Detection with ‘Notorious Virus’ Campaign

Hepatitis A, News

The National Restaurant Association (NRA) recently announced this year’s initiative as part of its ongoing commitment to food safety: a campaign themed “Notorious Virus,” with the goal to raise awareness about how to protect ... Read more

July 26, 2016July 26, 2016

Phase 1/1b Trial for Chronic Hepatitis B Therapy to Continue, Based on Safety Panel Recommendation

Hepatitis B, News

Based on preliminary positive safety data, a Safety Review Committee has recommended that a Phase 1/1b clinical trial be continued with TG1050, an immunotherapy candidate being developed by Transgene for ... Read more

July 21, 2016July 21, 2016

UN Health Agency Warns ‘World Has Ignored Hepatitis at Its Peril’

Hepatitis B, Hepatitis C, News

Noting that an estimated 400 million people around the world are infected with hepatitis B or C, the United Nations health agency is encouraging countries to increase hepatitis testing and ... Read more

July 19, 2016July 19, 2016

Investigational RNAi Therapy for Chronic Hepatitis B Starts Phase 1/2 Trial

Hepatitis B, News

A new RNAi treatment candidate for chronic hepatitis B (HBV) infection called ALN-HBV, has entered a Phase 1/2 clinical trial to evaluate its safety and efficacy in healthy volunteers and HBV ... Read more

July 5, 2016July 5, 2016

MassHealth Expands Access to Hepatitis C Therapies Like Harvoni

Hepatitis C, News

Leaders in Massachusetts recently took steps to ensure that all members of MassHealth, the state’s health insurance program for low- and moderate-income residents, have access to medications to treat hepatitis C. Following months of negotiations, MassHealth ... Read more

June 28, 2016June 28, 2016

First Hepatitis B Patients Treated in Study of New Therapy at Lower Doses Than Standard

Hepatitis B, News

ContraVir Pharmaceuticals announced the dosing of the first patients with chronic hepatitis B enrolled in its head-to-head Phase 2a clinical trial comparing multiple doses of the company’s lead candidate CMX157 to tenofovir disoproxil fumarate (TDF), a standard therapy. ... Read more

June 16, 2016June 16, 2016

Highly Effective Interferon-Free Therapies for Hepatitis C Shown to Diminish Portal Vein Hypertension in Austrian Study

Hepatitis C, News

New interferon-free treatments for patients with hepatitis C were shown to decrease hypertension of the portal vein — which carries blood from the gut to the liver — decreasing the risk of ... Read more

June 14, 2016June 14, 2016

Dynavax Presents Promising Data on Hepatitis-B Vaccine, Heplisav-B, for Type 2 Diabetics

Hepatitis B, News

Dynavax Technologies Corp. presented preliminary data from a Phase 3 study of its Heplisav-B vaccine against hepatitis B in adults with type 2 diabetes mellitus, showing the vaccine provided a higher rate of protection ... Read more

June 9, 2016June 9, 2016

GeoVax Launches New Program for Hepatitis B Vaccine

Hepatitis B, News

GeoVax Labs launched a promising program recently to develop a new vaccine for the treatment of chronic Hepatitis B infections. A clinical-stage biotechnology company, GeoVax develops human vaccines against infectious diseases through its ... Read more